Furthermore, we reported that the induction of EMT by TGF-β1 treatment in parent breast cancer cells resulted in the acquisition of mesenchymal morphology and up-regulation of the expression of CSCs markers. The gene discussed is TGFB1; the disease is breast carcinoma.